AllPennyStocks.com NVS Stock Clocks Worst Day In Over 20 Years After Second Trial Failure In A Week — DYN, SRPT Slip In Sympathy
This section contains press releases and other materials from third parties (including paid content). AllPennyStocks.com has not reviewed this content. Please see our disclaimer.

NVS Stock Clocks Worst Day In Over 20 Years After Second Trial Failure In A Week — DYN, SRPT Slip In Sympathy

The company said on Tuesday that its experimental drug del-desiran failed in a late-stage trial.

Other Penny Stock Movers

Digestive Health Expansion Sends This Microcap Soaring
Utah Copper Explorer Jumps 19% on Surface Assays
Indonesian Gold Developer Jumps 27% as Ministry Moves File to Final Approval
Most Popular
{{ index + 1 }}


Back to Top